These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23910235)

  • 1. Significance of XRCC1 Codon399 polymorphisms in Chinese patients with locally advanced nasopharyngeal carcinoma treated with radiation therapy.
    Zhai XM; Hu QC; Gu K; Wang JP; Zhang JN; Wu YW
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e125-32. PubMed ID: 23910235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of DNA base-excision repair XRCC1, OGG1 and APE1 gene polymorphisms with nasopharyngeal carcinoma susceptibility in a Chinese population.
    Li Q; Wang JM; Peng Y; Zhang SH; Ren T; Luo H; Cheng Y; Wang D
    Asian Pac J Cancer Prev; 2013; 14(9):5145-51. PubMed ID: 24175791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
    Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
    Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of induction docetaxel, platinum, and fluorouracil chemotherapy in patients with stage III or IVA/B nasopharyngeal cancer treated with concurrent chemoradiation therapy: Final results of 2 parallel phase 2 clinical trials.
    Kong L; Zhang Y; Hu C; Guo Y; Lu JJ
    Cancer; 2017 Jun; 123(12):2258-2267. PubMed ID: 28192641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neo-adjuvant Docetaxel and Cisplatin followed by concurrent Cisplatin with radiation therapy in treatment of locally advanced nasopharyngeal carcinoma.
    Hassan E; Galal K; Esmat E
    Gulf J Oncolog; 2008 Jan; (3):46-53. PubMed ID: 20084797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.
    Zhong YH; Dai J; Wang XY; Xie CH; Chen G; Zeng L; Zhou YF
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1577-83. PubMed ID: 23549883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.
    Kong L; Zhang YW; Hu CS; Guo Y
    Chin J Cancer; 2010 May; 29(5):551-5. PubMed ID: 20426907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
    Cheng XD; Lu WG; Ye F; Wan XY; Xie X
    J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population.
    Cao Y; Miao XP; Huang MY; Deng L; Hu LF; Ernberg I; Zeng YX; Lin DX; Shao JY
    BMC Cancer; 2006 Jun; 6():167. PubMed ID: 16796765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of concurrent chemoradiotherapy versus induction chemotherapy followed by radiation in patients with nasopharyngeal carcinoma.
    Komatsu M; Tsukuda M; Matsuda H; Horiuchi C; Taguch T; Takahashi M; Nishimura G; Mori M; Niho T; Ishitoya J; Sakuma Y; Hirama M; Shiono O
    Anticancer Res; 2012 Feb; 32(2):681-6. PubMed ID: 22287763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma.
    Jin H; Xie X; Wang H; Hu J; Liu F; Liu Z; Zhou J; Zhang Y; Xi X; Hu B; Liao Y; Tang J
    PLoS One; 2014; 9(7):e101256. PubMed ID: 25025378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.
    Kong L; Hu C; Niu X; Zhang Y; Guo Y; Tham IW; Lu JJ
    Cancer; 2013 Dec; 119(23):4111-8. PubMed ID: 24037893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of induction chemotherapy with vinorelbine plus cisplatin (NP) or docetaxel plus cisplatin (TP) combined with concurrent chemoradiotherapy for patients with locally advanced nasopharyngeal carcinoma].
    Han SH; Yu L; Zhang Z; Zhang PJ; Song HP; Guo CY
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):623-6. PubMed ID: 24314223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients.
    Li H; You Y; Lin C; Zheng M; Hong C; Chen J; Li D; Au WW; Chen Z
    Radiat Oncol; 2013 Feb; 8():31. PubMed ID: 23375119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study.
    Lu Y; Chen D; Liang J; Gao J; Luo Z; Wang R; Liu W; Huang C; Ning X; Liu M; Huang H
    BMC Cancer; 2019 Dec; 19(1):1262. PubMed ID: 31888551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of influence of XRCC1 and XPD gene polymorphisms on outcome of platinum-based chemotherapy for advanced non small cell lung cancers.
    Yao CY; Huang XE; Li C; Shen HB; Shi MQ; Feng JF; Pan LX; Tang JH
    Asian Pac J Cancer Prev; 2009; 10(5):859-64. PubMed ID: 20104979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy of docetaxel combined cisplatin (TP regimen) and cisplatin combined 5-fluorouracil (PF regimen) on locally advanced nasopharyngeal carcinoma].
    Xie FY; Qi SN; Hu WH; Zou GR; Peng M; Li JS
    Ai Zheng; 2007 Aug; 26(8):880-4. PubMed ID: 17697552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy.
    Teo PM; Chan AT; Lee WY; Leung TW; Johnson PJ
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):261-71. PubMed ID: 10030248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 polymorphisms and risk of nasopharyngeal carcinoma: a meta-analysis.
    Huang GL; Guo HQ; Yu CY; Liu XY; Li BB; Wu JJ; He ZW
    Asian Pac J Cancer Prev; 2011; 12(9):2329-33. PubMed ID: 22296379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy with weekly low-dose docetaxel and cisplatin concurrent with radiation for patients with locally advanced nasopharyngeal carcinoma, followed by adjuvant chemotherapy for selected patients.
    Nakahara S; Hanamoto A; Seo Y; Miyaguchi S; Yamamoto Y; Tomiyama Y; Yoshii T; Takenaka Y; Yoshioka Y; Isohashi F; Ogawa K; Inohara H
    Jpn J Clin Oncol; 2016 Oct; 46(10):903-910. PubMed ID: 27474126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.